Kaneka (KKA) Price & Analysis
KKA Stock Chart & Stats
- Day’s Range
- EUR 34.00 - EUR 34.40
- 52-Week Range
- EUR 21.40 - EUR 35.20
- Previous Close
- EUR 34.00
- Volume
- 0
- Average Volume (3M)
- 0
- Market Cap
- EUR 2.13B
- Enterprise Value
- EUR 541.67B
- Total Cash (Recent Filing)
- EUR 50.97B
- Total Debt (Recent Filing)
- EUR 231.31B
- Price to Earnings (P/E)
- 10.7
- Beta
- 0.70
- Next Earnings
- Nov 11, 2026
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 3.71%
Bulls Say, Bears Say
Bulls Say
Sustained Revenue Expansion
Continued revenue growth indicates durable demand across Kaneka’s end markets and supports operating scale. The trend also suggests the company can maintain customer relevance and pricing in specialty materials and healthcare-related applications.
Diversified B2B Product Portfolio
Kaneka’s broad B2B portfolio reduces dependence on a single application or customer industry. Exposure to industrial materials and healthcare-related products provides multiple avenues for recurring demand, while application-specific products can support customer retention.
Sound Balance Sheet And Positive Operating Cash Flow
Steady equity growth and moderate leverage provide a reasonable financial base for ongoing investment. Consistently positive operating cash flow also supports the quality of core earnings, even though free cash flow remains uneven.
Bears Say
Volatile Free Cash Flow
Uneven free cash flow limits financial flexibility and can constrain debt reduction, shareholder returns or growth investment. The recurring gap between accounting profits and cash generation suggests continued exposure to capital spending and working-capital swings.
Modest Profit Margins
Modest and fluctuating margins leave limited protection against raw-material inflation, weaker utilization or unfavorable product mix. This may prevent strong revenue growth from translating proportionally into earnings and reduce the resilience of profitability.
Moderate Leverage And Low Capital Returns
Although leverage remains moderate, debt has trended upward since 2022 while returns on equity remain only mid-single-digit. This combination indicates rising balance-sheet commitments without evidence of outsized capital productivity, limiting financial efficiency.
KKA FAQ
What was Kaneka’s price range in the past 12 months?
What is Kaneka’s market cap?
When is Kaneka’s upcoming earnings report date?
How were Kaneka’s earnings last quarter?
Is Kaneka overvalued?
Does Kaneka pay dividends?
What is Kaneka’s EPS estimate?
How many shares outstanding does Kaneka have?
What happened to Kaneka’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Kaneka?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Kaneka
Kaneka Corporation, established in Tokyo, Japan, in 1949, operates internationally as a diversified manufacturer providing a wide array of advanced materials and specialized products. Its core chemical business includes the production and global distribution of various polyvinyl chloride (PVC) formulations, such as crosslinked, paste, and chlorinated PVC, alongside acryl grafted-vinyl chloride copolymers. The company also supplies critical additives like impact modifiers, processing aids, specialty additives, and tougheners for thermosetting resins. Furthermore, their portfolio features advanced polymers including silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, biodegradable polymers, and engineering resins designed for injection molding, in addition to zero birefringence materials, acrylic films, and isobutylene-based thermoplastic elastomers. Beyond chemicals, Kaneka manufactures specialized foams and films, encompassing polypropylene and Kanelite foams, extruded polystyrene insulation, polyimide films, and transparent films for optical applications. Their material science expertise extends to high thermal conductive graphite sheets, multi-layer insulation, transparent conductive films, and transparent resins engineered for exceptional heat and light resistance. In the energy and innovative products sector, Kaneka offers photovoltaic power generation systems suitable for residential, public, and industrial installations. Other cutting-edge developments include eco-friendly fur, flame-retardant materials, hair accessories, novel materials, organic EL lighting panels, and biosurfactants. Their life sciences division delivers a comprehensive range of medical and pharmaceutical offerings, which include intervention and blood purification systems, gastroenterology intervention tools, diagnostic testing equipment, regenerative medicine and cell therapy solutions, and genetic diagnostics. Additionally, they provide low molecular pharmaceutical raw materials, affinity chromatography resins for monoclonal antibody purification, biopharmaceuticals, transdermal medicines, and innovative shock-absorbing innerwear. Lastly, Kaneka is a significant player in the food and nutrition industry. Their extensive product line features dairy products, margarines, fats and oils, whipping creams, fillings, baking essentials (baker's yeast, dough improvers), processed fruits, butter, shortening, cacao butter alternatives, various creams, frozen dough, spices, and antifreeze materials. They also supply pharmaceutical and supplemental nutrition solutions, such as coenzyme Q10, lactic-acid bacteria, and functional foodstuffs, alongside agricultural fertilizers.
- Sector
- Basicmaterials
- Industry
- Chemicals - Specialty
- CEO
- Kazuhiko Fujii
- Employees
- 11,762
- Website
- www.kaneka.co.jp
- Address
- 1-12-32, Akasaka, Tokyo, OS, 107-6028, JP
Kaneka (KKA) Earnings & Revenues
KKA Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 4 | 3 |
| Technical Analysis | 3 | 4 | 3 |
| Moving Averages | 12 | 0 | 0 |